| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 08/16/2001 | WO2000049132A3 Uses of transgenic animals containing a type x collagen mutant |
| 08/16/2001 | WO2000029589A8 Methioninase gene therapy for tumor treatment |
| 08/16/2001 | US20010013496 Method for controlling snails using dialkyl diallyl ammonium polymers |
| 08/16/2001 | EP1123405A1 Materials and methods involving conditional aggregation domains |
| 08/16/2001 | EP1123397A2 G-protein coupled receptors |
| 08/16/2001 | EP1123388A1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
| 08/16/2001 | EP1123383A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/16/2001 | EP1122997A1 Method for localizing allantoic fluid of avian eggs |
| 08/16/2001 | CA2400802A1 Compositions and methods for screening therapeutic agents |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2399349A1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/14/2001 | US6274788 Bicistronic DNA construct comprising X-myc transgene for use in production of transgenic animal model systems for human hepatocellular carcinoma and transgenic animal model systems so produced |
| 08/14/2001 | US6274338 Human c-Maf compositions and methods of use thereof |
| 08/09/2001 | WO2001057242A2 Methods of protein destabilization and uses thereof |
| 08/09/2001 | WO2001057216A2 Method for the production of a protein |
| 08/09/2001 | WO2001057194A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | WO2001057088A1 RUMINANT MHC CLASS I-LIKE Fc RECEPTORS |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057079A2 C1 inhibitor produced in the milk of transgenic mammals |
| 08/09/2001 | WO2001057057A1 Mammalian sphingosine-1-phosphate phosphatase |
| 08/09/2001 | WO2001056376A1 Transgenic non-human animal overexpressing gli-1, as a cancer model system |
| 08/09/2001 | WO2001056375A1 Tob gene-defective knockout nonhuman mammal |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2000069257A3 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 08/09/2001 | WO2000058510A3 Schizophrenia associated genes, proteins and biallelic markers |
| 08/09/2001 | US20010013134 Transgenic mammal; polynucleotide containing pancreas promoter |
| 08/09/2001 | US20010012983 Methods for determining therapeutic index from gene expression profiles |
| 08/09/2001 | US20010012516 Viral vectors |
| 08/09/2001 | CA2400013A1 Methods of protein destabilization and uses thereof |
| 08/09/2001 | CA2399982A1 G-protein coupled receptors |
| 08/09/2001 | CA2399683A1 Mammalian sphingosine-1-phosphate phosphatase |
| 08/09/2001 | CA2399561A1 Ruminant mhc class i-like fc receptors |
| 08/09/2001 | CA2396774A1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/08/2001 | EP1122314A1 Method for the production of a protein |
| 08/08/2001 | EP1121454A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 08/08/2001 | EP1121374A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 08/07/2001 | US6271436 Cells and methods for the generation of transgenic pigs |
| 08/07/2001 | US6271435 Leukotriene B4 receptor transgenic mice |
| 08/07/2001 | US6271363 Nucleotide sequences coding morphology determining polypeptides; for diagnosis and treatment of cell proliferation and differentiation defects; for treatment of urogenital and osteogenic defects |
| 08/07/2001 | US6271360 Single-stranded oligodeoxynucleotide mutational vectors |
| 08/07/2001 | US6271348 Fusion protein which inhibits transcription in eukaryotic cells; for use as a tool in gene regulation |
| 08/07/2001 | US6271341 Fusion protein associated with the control of gene expression; for use as a tool in controlled gene expression |
| 08/07/2001 | US6270994 Smad6 and uses thereof |
| 08/07/2001 | US6270778 Relates to genes encoding melanoma antigens recognized by t-cells and their corresponding proteins. |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001013932A3 Stimulation of sperm function |
| 08/02/2001 | WO2000056932A3 Germline-competent avian cells |
| 08/02/2001 | WO2000036106A9 Non-invasive evaluation of physiological response in a mammal |
| 08/02/2001 | WO2000023602A3 Regulated expression using conditional er retention domains |
| 08/02/2001 | US20010011073 Uses of transgenic animals containing a type X collagen mutant |
| 08/01/2001 | EP1120655A2 A method for detecting an aberrant animal-derived prion gene and prion gene modified mouse which exhibits heart anomalies |
| 08/01/2001 | EP1120037A2 A construction including an implement for milking animals |
| 08/01/2001 | EP1119625A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 08/01/2001 | EP1119614A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | CN2440326Y Artificial insect ovipositor |
| 08/01/2001 | CN1306568A Human bile salt-stimulated lipase (BSSL) obtainable from transgenic sheep |
| 08/01/2001 | CN1306390A Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
| 08/01/2001 | CN1305702A Natural enclosing method for raising forest frog |
| 08/01/2001 | CN1069019C Conveyance tech. for breeding of fryer |
| 07/31/2001 | US6268487 Purification of biologically active peptides from milk |
| 07/31/2001 | US6268482 Recombinant cytokine designated LERK-6 |
| 07/31/2001 | US6268212 Tissue specific transgene expression |
| 07/31/2001 | US6268211 Transgene of complete human immunodeficiency virus genome except having 5'long terminal repeat, portion of 5'leader, and portion of 3' long terminal repeat deleted; also includes regulatory sequences for gene expression; animal models |
| 07/31/2001 | US6268138 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs |
| 07/27/2001 | CA2332657A1 A method for detecting an aberrant animal-derived prion gene and a prion gene modified mouse which exhibits heart anomalies |
| 07/26/2001 | WO2001053825A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 07/26/2001 | WO2001053824A1 Mouse model for rheumatoid arthritis |
| 07/26/2001 | WO2001053538A2 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease |
| 07/26/2001 | WO2001053518A2 Method of assessing the viability of a cell |
| 07/26/2001 | WO2001053508A2 Methods for raising rabbits |
| 07/26/2001 | WO2001053473A2 Methods for amplifying genetic material and uses thereof |
| 07/26/2001 | WO2001053468A2 Lipid metabolism enzymes and polynucleotides encoding them |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053340A2 Transgenic mouse model of human neurodegenerative disease |
| 07/26/2001 | WO2001052643A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor |
| 07/26/2001 | WO2001052642A1 Method of transferring mutant mitochondrial dna into genital cells |
| 07/26/2001 | CA2436918A1 Methods for amplifying genetic material and uses thereof |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398243A1 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease |
| 07/26/2001 | CA2397946A1 Lipid metabolism enzymes |
| 07/26/2001 | CA2397931A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 07/26/2001 | CA2397646A1 Mouse model for rheumatoid arthritis |
| 07/26/2001 | CA2396969A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor |
| 07/25/2001 | EP1118603A2 Process for the transformation of organic remains into organic fertilizer and by-products and worm breeding |
| 07/25/2001 | EP1117784A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 07/25/2001 | EP1117782A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/25/2001 | EP1117774A1 Method for generating diversity |
| 07/25/2001 | EP1117766A1 Method and apparatus for the storage of entomopathogenic nematodes |
| 07/25/2001 | EP1117763A1 Method for producing cloned tigers by employing inter-species nuclear transplantation technique |
| 07/25/2001 | EP1117427A2 USE OF $i(PEX) IN THE TREATMENT OF METABOLIC BONE DISEASES |
| 07/25/2001 | CN2439860Y Sterilized isolator |
| 07/25/2001 | CN1305525A Phagocytic assay method |
| 07/25/2001 | CN1304651A Technique for increasing survivalrate of one-age young forest frog in the field |
| 07/25/2001 | CN1304650A Technique for increasing metamorphotic rate of forest frog tadpoles in the field |
| 07/25/2001 | CN1304649A Technique for increasing hatchability of forest frog cytulos in the field |
| 07/25/2001 | CN1304648A Technique for increasing survival rate of forest frog tadpoles in the field |
| 07/24/2001 | US6265632 Animal model for fibroblast growth factor receptor associated chondrodysplasia |